Across TCGA pan-cancer cohorts, CDY5P RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated CDY5P data layer.
The strongest signal is observed in esophageal carcinoma (ESCA), where higher CDY5P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CDY5P expression acts as an unfavorable survival marker.
ESCA are the cancer types where CDY5P RNA most reproducibly stratifies survival.